BridgeMD
New treatment option for Polypharmacy
Official title Reduction of Polypharmacy in Elderly People With Multiple Diseases
ClinicalTrials.gov ID: NCT05526963
What this study is testing
- What it's testing
- Elderly GP patients are often treated with five or more medications and therefore prone to adverse drug reactions (ADR). Potentially inappropriate prescriptions (PIPs) lead to increased adverse events like falls, hospitalizations and mortality.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 70 and older
You may be able to join if
- ≥ 5 longterm medications (\> 6 months) (polypharmacy)
- ≥ 3 chronic diseases (multimorbidity)
- ≥ 1 family doctor consultation within the last 6 months
You likely can't join if
- Patients with a critically reduced life expectancy
- Patients who cannot autonomously visit the family practice
- Patients who cannot participate in the informed consent process
- Patients who are residing in a nursing home
- Patients with dementia or a mental of behavioral disorder ICD-10 F00-F99
- Patients who are participating in another medical study with a focus on polypharmacy or multimorbidity
The study team makes the final eligibility decision.
Where it's taking place
- Halle, Saxony-Anhalt, Germany
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 70 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halle, Saxony-Anhalt, Germany. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.